# OnCo record codel (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/codel/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "codel", "NCT00887146" ;
  schema:name "CODEL"@en ;
  schema:description "CODEL is the intergroup trial meant to settle whether oligodendroglioma patients should get temozolomide or the older three-drug PCV combination with their radiotherapy; its first phase already showed that temozolomide on its own, without radiotherapy, lets the tumour come back sooner."@en ;
  schema:url <https://onco.cc/trials/codel/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00887146> ;
  onco:status "active" ;
  onco:tag "subtype-trials" ;
  onco:phase "3" ;
  onco:related <https://onco.cc/key-papers/paper-eortc-26951-van-den-bent-jco-2013/> ;
  onco:cancers <https://onco.cc/cancers/oligodendroglioma/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:drugs <https://onco.cc/drugs/temozolomide/>, <https://onco.cc/drugs/procarbazine/>, <https://onco.cc/drugs/lomustine/>, <https://onco.cc/drugs/vincristine/> ;
  onco:institutions <https://onco.cc/institutions/alliance-oncology/> .